Reversible and Species-specific Depigmentation Effects of Azd3293, a Bace Inhibitor for the Treatment of Alzheimer’s Disease, Are Related to Bace2 Inhibition and Confined to Epidermis and Hair
Year: 2016
Type: article
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: bronze
Funders: Eli Lilly and Company, AstraZeneca
OpenAlex ID: W2580483010
